BUZZ-与诺华公司达成 57 亿美元许可协议后，蒙地罗萨公司业绩大涨

路透中文

Sep 15

BUZZ-与<a href="https://laohu8.com/S/NVS">诺华</a>公司达成 57 亿美元许可协议后，蒙地罗萨公司业绩大涨

更新

9月15日 - ** Monte Rosa Therapeutics GLUE.O股价大涨35.6% 至 6.52美元

** 如果涨势保持，股价将创下10个多月来最大单日涨幅

** 公司称已与瑞士制药商诺华NOVN.S达成协议 (link)，合作开发治疗免疫介导疾病的药物

** 交易包括向 Monte Rosa 支付 1.2 亿美元的预付款，该公司有资格获得总额高达 57 亿美元的里程碑付款和各项目期权付款

** Wedbush分析师罗伯特-德里斯科尔（Robert Driscoll）表示，这笔交易意味着蒙特罗萨公司的分子胶降解剂发现平台从现有的大型制药合作伙伴那里得到了进一步验证。

** 在美国上市的诺华公司股价下跌 1%，报 122.81 美元。

** 包括盘中走势在内，GLUE 下跌 6.6%，NVS 今年累计上涨 26

(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2567148830"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2567148830\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2567148830?lang=en_US&edition=fundamental","thumbnail":"","is_english":false,"pubTime":"2025-09-15 22:37","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2567148830","market":"us","top_or_hot":-1,"title":"BUZZ-与诺华公司达成 57 亿美元许可协议后，蒙地罗萨公司业绩大涨","media":"路透中文","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-与<a href=\"https://laohu8.com/S/NVS\">诺华</a>公司达成 57 亿美元许可协议后，蒙地罗萨公司业绩大涨</title></head><body><p>更新</p><p>\n<span>9月15日</span><span> - </span>** <a href=\"https://laohu8.com/S/GLUE\">Monte Rosa Therapeutics</a> <span>GLUE.O</span>股价大涨<span>35.6% </span>至 6<span>.52</span>美元</p><p>*<span>* 如果涨势保持，股价将创下10个多月来最大单日涨幅</span></p><p>** 公司称已与瑞士制药商诺华<span>NOVN.S</span>达成协议 (<span>link</span>)，合作开发治疗免疫介导疾病的药物</p><p>** 交易包括向 Monte Rosa 支付 1.2 亿美元的预付款，该公司有资格获得总额高达 57 亿美元的里程碑付款和各项目期权付款</p><p>*<span>* Wedbush分析师罗伯特-德里斯科尔（Robert Driscoll）表示，这笔交易意味着蒙特罗萨公司的分子胶降解剂发现平台从现有的大型制药合作伙伴那里得到了进一步验证</span>。</p><p>\n<span> ** 在美国上市的诺华公司股价下跌 1%，报 122.81 美元。</span>\n</p><p>*<span>* 包括盘中走势在内</span>，<span>GLUE</span> <span>下跌 6.6%，NVS </span>今年累计<span>上涨 26 </span></p><p>(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BUZZ-与诺华公司达成 57 亿美元许可协议后，蒙地罗萨公司业绩大涨</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBUZZ-与诺华公司达成 57 亿美元许可协议后，蒙地罗萨公司业绩大涨\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1098195322\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">路透中文 </p>\n<p class=\"h-time\">2025-09-15 22:37</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-与<a href=\"https://laohu8.com/S/NVS\">诺华</a>公司达成 57 亿美元许可协议后，蒙地罗萨公司业绩大涨</title></head><body><p>更新</p><p>\n<span>9月15日</span><span> - </span>** <a href=\"https://laohu8.com/S/GLUE\">Monte Rosa Therapeutics</a> <span>GLUE.O</span>股价大涨<span>35.6% </span>至 6<span>.52</span>美元</p><p>*<span>* 如果涨势保持，股价将创下10个多月来最大单日涨幅</span></p><p>** 公司称已与瑞士制药商诺华<span>NOVN.S</span>达成协议 (<span>link</span>)，合作开发治疗免疫介导疾病的药物</p><p>** 交易包括向 Monte Rosa 支付 1.2 亿美元的预付款，该公司有资格获得总额高达 57 亿美元的里程碑付款和各项目期权付款</p><p>*<span>* Wedbush分析师罗伯特-德里斯科尔（Robert Driscoll）表示，这笔交易意味着蒙特罗萨公司的分子胶降解剂发现平台从现有的大型制药合作伙伴那里得到了进一步验证</span>。</p><p>\n<span> ** 在美国上市的诺华公司股价下跌 1%，报 122.81 美元。</span>\n</p><p>*<span>* 包括盘中走势在内</span>，<span>GLUE</span> <span>下跌 6.6%，NVS </span>今年累计<span>上涨 26 </span></p><p>(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4539","symbol_name":"次新股","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250915:nL3T3V20W8:1","article_id":"2567148830","we_media_id":"1098195322","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2567148830","pubTimestamp":1757947064,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"路透中文","introduction":"路透中文","home_visible":1,"id":"1098195322","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"** 在美国上市的诺华公司股价下跌 1%，报 122.81 美元。** 包括盘中走势在内，GLUE 下跌 6.6%，NVS 今年累计上涨 26 (为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4539":"次新股","BK4139":"生物科技","GLUE":"Monte Rosa Therapeutics"},"translate_title":"BUZZ-Monte Rosa surges after $5.7 billion licensing deal with Novartis","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"GLUE":0.9},"content_text":"BUZZ-与诺华公司达成 57 亿美元许可协议后，蒙地罗萨公司业绩大涨更新\n9月15日 - ** Monte Rosa Therapeutics GLUE.O股价大涨35.6% 至 6.52美元** 如果涨势保持，股价将创下10个多月来最大单日涨幅** 公司称已与瑞士制药商诺华NOVN.S达成协议 (link)，合作开发治疗免疫介导疾病的药物** 交易包括向 Monte Rosa 支付 1.2 亿美元的预付款，该公司有资格获得总额高达 57 亿美元的里程碑付款和各项目期权付款** Wedbush分析师罗伯特-德里斯科尔（Robert Driscoll）表示，这笔交易意味着蒙特罗萨公司的分子胶降解剂发现平台从现有的大型制药合作伙伴那里得到了进一步验证。\n ** 在美国上市的诺华公司股价下跌 1%，报 122.81 美元。\n** 包括盘中走势在内，GLUE 下跌 6.6%，NVS 今年累计上涨 26 (为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}